Point-of-Care Technologies for the Advancement of Precision Medicine in Heart , Lung , Blood , and Sleep Disorders

The commercialization of new point of care technologies holds great potential in facilitating and advancing precision medicine in heart, lung, blood, and sleep (HLBS) disorders. The delivery of individually tailored health care to a patient depends on how well that patient's health condition can be interrogated and monitored. Point of care technologies may enable access to rapid and cost-effective interrogation of a patient's health condition in near real time. Currently, physiological data are largely limited to single-time-point collection at the hospital or clinic, whereas critical information on some conditions must be collected in the home, when symptoms occur, or at regular intervals over time. A variety of HLBS disorders are highly dependent on transient variables, such as patient activity level, environment, time of day, and so on. Consequently, the National Heart Lung and Blood Institute sponsored a request for applications to support the development and commercialization of novel point-of-care technologies through small businesses (RFA-HL-14-011 and RFA-HL-14-017). Three of the supported research projects are described to highlight particular point-of-care needs for HLBS disorders and the breadth of emerging technologies. While significant obstacles remain to the commercialization of such technologies, these advancements will be required to achieve precision medicine.

[1]  Ulrich Friess,et al.  Cardiac markers: a clear cause for point-of-care testing , 2009, Analytical and bioanalytical chemistry.

[2]  Peng Li,et al.  An acoustofluidic sputum liquefier. , 2015, Lab on a chip.

[3]  Tony Jun Huang,et al.  An acoustofluidic micromixer based on oscillating sidewall sharp-edges. , 2013, Lab on a chip.

[4]  Chi On Chui,et al.  Novel T-channel nanowire FET with built-in signal amplification for pH sensing , 2009, 2009 IEEE International Electron Devices Meeting (IEDM).

[5]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[6]  Mark D. Huffman,et al.  AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .

[7]  Kevin W Plaxco,et al.  Switch-based biosensors: a new approach towards real-time, in vivo molecular detection. , 2011, Trends in biotechnology.

[8]  C. Lindsell,et al.  Comparison of the HEART and TIMI Risk Scores for Suspected Acute Coronary Syndrome in the Emergency Department. , 2016, Critical pathways in cardiology.

[9]  H. Mcdonald,et al.  Interventions to enhance patient adherence to medication prescriptions: scientific review. , 2002, JAMA.

[10]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care. , 2013, European heart journal.

[11]  C. Lotan,et al.  Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. , 2007, Archives of internal medicine.

[12]  J. Csicsvari,et al.  Massively parallel recording of unit and local field potentials with silicon-based electrodes. , 2003, Journal of neurophysiology.

[13]  Thierry Troosters,et al.  Physical activity and hospitalization for exacerbation of COPD. , 2006, Chest.

[14]  C. Mueller,et al.  Serial changes in highly sensitive cardiac troponin improve the early diagnosis of acute myocardial infarction , 2012, Evidence-Based Medicine.

[15]  Xiang Wang,et al.  Semiconductor Electronic Label-Free Assay for Predictive Toxicology , 2016, Scientific Reports.

[16]  A. Sparreboom,et al.  Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents , 2012, British Journal of Cancer.

[17]  S. Martin,et al.  Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study , 2006, Diabetologia.

[18]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[19]  Ralph Weissleder,et al.  Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research , 2016, JACC. Basic to translational science.

[20]  박정호,et al.  Schottky Contacted Nanowire Field-Effect Sensing Device With Intrinsic Amplification , 2010 .

[21]  D. Fabian,et al.  The global burden of asthma: executive summary of the GINA Dissemination Committee Report , 2004, Allergy.

[22]  Stefan Blankenberg,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[23]  S. Swain,et al.  Congestive heart failure in patients treated with doxorubicin , 2003, Cancer.

[24]  C. Albus,et al.  [Interventions to enhance adherence to medication]. , 2014, MMW Fortschritte der Medizin.

[25]  J. Fahy,et al.  Acute exacerbations of asthma: epidemiology, biology and the exacerbation‐prone phenotype , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  Richard Beale,et al.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis , 2010, Intensive Care Medicine.

[27]  S. Russell.  Progress of artificial pancreas devices towards clinical use: the first outpatient studies , 2015, Current opinion in endocrinology, diabetes, and obesity.

[28]  S. Wallace,et al.  Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. , 1982, Annals of internal medicine.

[29]  M. Kraft.  Asthma phenotypes and interleukin-13--moving closer to personalized medicine. , 2011, The New England journal of medicine.

[30]  T. Huang,et al.  Continuous particle separation in a microfluidic channel via standing surface acoustic waves (SSAW). , 2009, Lab on a chip.

[31]  U. Aguirre,et al.  Impact of changes in physical activity on health-related quality of life among patients with COPD , 2010, European Respiratory Journal.

[32]  Fred S Apple,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Circulation.

[33]  Teofilo L. Lee-Chiong,et al.  Sleep: a comprehensive handbook , 2006 .

[34]  Christopher L. Perdue,et al.  Supportive Care of the First 2 Ebola Virus Disease Patients at the Monrovia Medical Unit. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  P. Collinson,et al.  High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study , 2015, The Lancet.

[36]  Peng Li,et al.  Standing surface acoustic wave (SSAW)-based cell washing. , 2015, Lab on a chip.

[37]  A. Santoro,et al.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  Lin Wang,et al.  Standing surface acoustic wave (SSAW) based multichannel cell sorting. , 2012, Lab on a chip.

[39]  J. Kientz,et al.  Consumer Sleep Technologies: A Review of the Landscape. , 2015, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[40]  M. S. Krause,et al.  Theory of square wave voltammetry , 1969 .

[41]  J. P. McCoy,et al.  Standing surface acoustic wave (SSAW)-based microfluidic cytometer. , 2014, Lab on a chip.

[42]  James McCord,et al.  Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I , 2001, Circulation.

[43]  R. Luepker,et al.  Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey. , 2012, Clinical chemistry.

[44]  Arica A Lubin,et al.  Continuous, real-time monitoring of cocaine in undiluted blood serum via a microfluidic, electrochemical aptamer-based sensor. , 2009, Journal of the American Chemical Society.